7-Night Alaska Hubbard Glacier Cruise
Round-trip Vancouver, British Columbia
August 10 - 17, 2025
Celebrity Solstice
16.0 AMA PRA Category 1 Credits™ 16 ACPE Credits 16.0 Contact Hours
Course Fees
$995 for Physicians, Attorneys, Psychologists, Doctors of Pharmacy, & Dentists $795 for Physician Assistants $595 for Nurses, Residents, Students & Others
Discuss the ACCP and Canadian Thoracic Society published guidelines for prevention of acute exacerbations of COPD
Discuss the data that shaped these guidelines as related to: 1.Medication Recommendations, 2. Non-medications Recommendations
Discuss data on surgical and non-surgical lung volume reduction in patients with COPD.
Discuss data on NIV for stable and acute COPD management
Discuss New areas of investigation.
Asthma
Discuss the prevalence and economic impact of asthma
Examine the pathophysiology of asthma
Discuss strategies for management of asthma patients with acute respiratory failure
Discuss expert consensus recommendations and application of these recommendations for accessing asthma control and disease management
Discuss updated expert consensus recommendations for long term asthma management
Examine data on recently FDA approved medications and bronchoscopic interventions used to treat severe persistent asthma
Pulmonary Nodules and Lung Cancer Screening: Understanding and Applying the Society Recommendations
Describe characteristics of pulmonary nodules that influence clinical suspicion for benign versus malignant
Discuss the Fleischner Society Guideline recommendations for following incidental pulmonary nodules noted on CT scans of the chest
Discuss Lung Cancer Screening Guidelines.
Discuss Lung-RADS: the structured reporting system for interpretation of lung cancer screening CT examinations. Understand the difference in the Fleischner Guidelines and Lung Cancer Screening guidelines as related to nodule management
Discuss risk factors forS developing ARDS as well as the differential diagnosis of patients presenting with acute hypoxic respiratory failure and bilateral pulmonary infiltrates
Examine data on the use of non-invasive ventilation and high flow nasal cannula for management patients with hypoxic respiratory failure. Recognize clinical parameters suggesting failure of these modes of respiratory support
Understand the current recommendations regarding mechanical ventilation and management of patients with ARDS.
Discuss the benefits and how to implement alternative treatments in patients with severe ARDS including: prone positioning, ECMO, paralytics, and vasodilators
Pulmonary Embolism: Treating Patients Based on Risk Stratification, Evidence-Based Guidelines
Discuss the Risk Stratification for Acute Pulmonary Embolism
Identify Clinical Tools, Radiological Imaging, and Laboratory Markers Used in Risk Stratification of Acute Pulmonary Embolism
Discuss Current ACCP Recommendations for Treatment of Acute Pulmonary Embolism
Discuss Data on Treatment Outcomes of Patients with High and Intermediate Risk Acute Pulmonary Embolism Treated with Thrombolyis, Catheter Directed Thrombolyis, and Standard Anticoagulation
Discuss Data on Long Term Follow-up from Patients with High and Intermediate Risk PE Treated with Thrombolysis versus Standard Anticoagulation
Review Current ACCP Recommendation for Duration of Treatment of Acute Pulmonary Embolism
Sleep Apnea Treatment Options: PAP, PACERS, and Beyond
Discuss the clinical benefit of weight loss and positional sleep therapy as treatment for OSA
Discuss data on medical interventions as related to treatment for OSA
Discuss data on Provent nasal device as related to treatment of OSA
Discuss data on dental devices as related to treatment for OSA
Discuss data on various surgical interventions as related to treatment of OSA
Discuss data on use of upper-airway stimulators for treatment of sleep apnea
Discuss data on use of diaphragm pacing in patients with central sleep apnea
Interstitial Lung Disease Part 1: Idiopathic Pulmonary Fibrosis and Sarcoid.
Discuss the broad differential diagnosis of diffuse parenchymal lung disease
Discuss the ATS/ERS diagnostic criteria for IPF and CT findings characteristic of IPF
Understand the various clinical measures predictive of survival in IPF
Discuss data that resulted in FDA approval for two drugs for treatment of IPF
Discuss the ATS/ERS guidelines for treatment of IPF
Understand the clinical presentation of pulmonary sarcoidosis.
Discuss the ERS clinical practice guidelines for treatment of sarcoidosis as related to organ involvement
Interstitial Lung Disease Part 2: Hypersensitivity Pneumonitis and Non-Cystic Fibrosis Bronchiectasis
DiscussATS/ERS practice guidelines for diagnosis and management of hypersensitivity pneumonitis
Examine CT findings for fibrotic and non-fibrotic HP
Discuss the pathogenesis of Non-Cystic Fibrosis bronchiectasis
Explain the work-up to determine the etiology of non-CF bronchiectasis
Discuss how to manage patients with non-CF bronchiectasis
Discuss management strategies in patients with acute exacerbations of non-CF bronchiectasis
Venovenous Extracorporeal Membrane Oxygen
Hypertensive Emergency
Cardiac Arrest
ARF and Oxygen<.li>
Climate Change and Sepsis
Acute Liver Failure
Fluid Responsiveness in Shock 2024
Critical Care below the Diaphragm
Conference Sessions generally take place on days at sea (as itinerary allows), giving you plenty of time to enjoy your meals, evenings and ports of call with your companion, family and friends.
IMPORTANT NOTE: All conferees, their families, and guests must book their cruise within the University at Sea® meeting group through University at Sea® at 800-926-3775 or by registering online. This ensures our company can provide conference services and complimentary social amenities to all meeting participants and their guests. Thank you for your cooperation.
Faculty
Stephen R. Clum, MD, PhD
Assistant Professor
Department of Internal Medicine
Division: Pulmonary, Critical Care, Sleep Medicine
University of South Florida
Tampa, FL
Associate Professor of Medicine, University of Central Florida
Chief of Pulmonary and Sleep Medicine at Bay Bines VA, St. Petersburg, FL
Stephen Clum, MD PhD
Dr. Clum earned his PhD in biochemistry at the University of Kansas. His PhD studies involve characterization of the dengue virus type II serine protease. After completing his PhD, he then pursued his medical degree at the University of Kansas. Following completion of his medical school training, he completed a combined residency in Internal Medicine and Pediatrics at University of South Florida. He remained at University of South Florida for fellowship training in Pulmonary, Critical Care, and Sleep Medicine.
After completing his fellowship training, he moved to Springfield Missouri where he joined a multispecialty group. His practice encompassed Pulmonary, Critical Care, Sleep Medicine including an active pediatric sleep practice. In 2014, he returned to the University South Florida to join the faculty in the Division of Pulmonary, Critical Care, and Sleep Medicine where he served as the associated division director. In this role he was actively involved in expansion of inpatient and outpatient services at Tampa General Hospital and USF. Following the retirement of his mentor, he served as the interim division director until the fall of 2020 when he joined the Bay Pines VA Healthcare System as the Chief of Pulmonary and Sleep Medicine. In his current role as Chief of Pulmonary and Sleep Medicine, he has helped developed a robust pulmonary nodule program, COPD program, and ILD program. At both the University of South Florida and Bay Pines VA, Dr. Clum has been a core faculty involved in the education of Pulmonary, Critical Care, and Sleep Medicine fellows.
JT Tina Chen, MD, MS
Associate Clinical Professor
Department of Medicine, Division of Pulmonary and Critical Care Medicine
University of California, San Francisco San Francisco, CA
Our staff can assist you with all your travel arrangements.
Questions? Call us at 800-422-0711.
We can assist you with all your travel arrangements. We'd be happy to help you plan your flights, hotels or tours before and/or after your cruise conference.
Cruise Itinerary
DATE
PORT OF CALL
ARRIVE
DEPART
Sun Aug 10
Vancouver, British Columbia
-
4:30 pm
Mon Aug 11
Alaska Inside Passage
-
-
Tue Aug 12
Icy Strait Point, Alaska
1:30 pm
9:00 pm
Wed Aug 13
Hubbard Glacier
9:30 am
2:30 pm
Thu Aug 14
Juneau, Alaska
7:30 am
7:00 pm
Fri Aug 15
Ketchikan, Alaska
2:00 pm
8:30 pm
Sat Aug 16
Alaska Inside Passage
-
-
Sun Aug 17
Vancouver, British Columbia
6:00 am
-
*Tentative course schedule, actual class times may differ.
Ports of Call
Vancouver, British Columbia - Sophisticated. Culturally diverse, this beautiful port city brims with attractions. From Vancouver's cosmopolitan downtown to the historically renovated Gastown district and exotic Chinatown, Vancouver displays varied urban scenes. Nestled near the city center is Stanley Park, resplendent with its deep forest, totem poles, and scenic promenades.
Non-US/Canadian individuals, please Click here to determine if you will need a visa to board this cruise which visits Canada.
Alaska Inside Passage - Winding along the breathtaking coast of Alaska, the Inside Passage offers magnificent views of forested islands, rock-walled fjords and snowcapped mountains. Richly diverse flora and fauna are also on display.
Icy Strait Point, Alaska
- Icy Strait Point, unlike most Alaskan cruise destinations, is privately held by The Huna Totem Corporation - a company established as part of the 1971 Alaska Native Claims Settlement Act and owned by over a thousand Alaskan Natives. With the cruise business making up over half of the local economy, Icy Strait Point goes to great lengths to maintain its historic charm.
Hubbard Glacier - Marching to the beat of a different drum, Hubbard Glacier is advancing while the rest of Alaska's ice rivers are receding rapidly. In 1986, Hubbard galloped forward, closing off Russell Fjord to create an entirely new lake. The phenomenon quickly passed and was followed by a short retreat, but the glacier is once again on the move and Russell Fjord is headed for another spell as an inland body of water.
Juneau, Alaska - You can’t get to Juneau easily without a sprint by air or by sea. But once you arrive you’ll find majestic views and rich culture in every corner. With its snowcapped mountains, misty rainforests, massive glaciers and bounty of wildlife, Alaska’s remote state capital is the perfect place to dive into nature. Framed by Mount Juneau and Mount Roberts, the city’s picturesque downtown area offers centuries-old bars, boutique shops and historic landmarks. For a taste of the local culture, visit the historic district and the Alaska State Museum. And for outdoor thrills, you can take your pick of activities ranging from whale watching in Auke Bay Harbor to tundra trekking over Mendenhall Glacier, and even try your hand at gold panning in Last Chance Basin.
Ketchikan, Alaska - Ketchikan sits at the southern end of Alaska’s Inside Passage— a gateway to the wild landscapes and seascapes of Misty Fjords National Monument. The canned salmon capital of the world, it’s a hub for fishing and outdoor sports. It’s also home to three tribes of Northwest Coast Native Americans, making it a great place to get a taste for the local culture. You’ll see it in the colorful, hand-carved totems that line the city’s streets and parks, and in the unique stilted homes that cling to Deer Mountain’s slopes. If you want to get up close and personal with nature, venture into the Tongass National Forest, the largest in the United States. Or head to Ketchikan Creek Waterfall for amazing views of downtown Ketchikan and a glimpse at the yearly salmon runs.
Our staff can assist you with all your travel arrangements.
Questions? Call us at 800-422-0711.
We can assist you with all your travel arrangements. We'd be happy to help you plan your flights, hotels or tours before and/or after your cruise conference.